16-1210360-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_021098.3(CACNA1H):c.3846-10G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 0 hom., cov: 0)
Exomes 𝑓: 0.23 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
CACNA1H
NM_021098.3 intron
NM_021098.3 intron
Scores
2
Splicing: ADA: 0.00001511
2
Clinical Significance
Conservation
PhyloP100: -2.79
Publications
1 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-1210360-G-C is Benign according to our data. Variant chr16-1210360-G-C is described in ClinVar as Likely_benign. ClinVar VariationId is 706988.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | NM_021098.3 | MANE Select | c.3846-10G>C | intron | N/A | NP_066921.2 | |||
| CACNA1H | NM_001005407.2 | c.3846-10G>C | intron | N/A | NP_001005407.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | TSL:1 MANE Select | c.3846-10G>C | intron | N/A | ENSP00000334198.7 | |||
| CACNA1H | ENST00000569107.6 | TSL:1 | c.3846-10G>C | intron | N/A | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.3846-10G>C | intron | N/A | ENSP00000518778.1 |
Frequencies
GnomAD3 genomes AF: 0.152 AC: 1643AN: 10774Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
1643
AN:
10774
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.239 AC: 9576AN: 40034 AF XY: 0.234 show subpopulations
GnomAD2 exomes
AF:
AC:
9576
AN:
40034
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.225 AC: 25156AN: 111784Hom.: 0 Cov.: 0 AF XY: 0.226 AC XY: 13637AN XY: 60390 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
25156
AN:
111784
Hom.:
Cov.:
0
AF XY:
AC XY:
13637
AN XY:
60390
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
899
AN:
3290
American (AMR)
AF:
AC:
2637
AN:
7576
Ashkenazi Jewish (ASJ)
AF:
AC:
714
AN:
3492
East Asian (EAS)
AF:
AC:
715
AN:
3768
South Asian (SAS)
AF:
AC:
4295
AN:
15712
European-Finnish (FIN)
AF:
AC:
777
AN:
4558
Middle Eastern (MID)
AF:
AC:
76
AN:
808
European-Non Finnish (NFE)
AF:
AC:
13904
AN:
67708
Other (OTH)
AF:
AC:
1139
AN:
4872
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.331
Heterozygous variant carriers
0
1433
2866
4299
5732
7165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.152 AC: 1644AN: 10828Hom.: 0 Cov.: 0 AF XY: 0.134 AC XY: 776AN XY: 5798 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1644
AN:
10828
Hom.:
Cov.:
0
AF XY:
AC XY:
776
AN XY:
5798
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
435
AN:
2978
American (AMR)
AF:
AC:
111
AN:
1674
Ashkenazi Jewish (ASJ)
AF:
AC:
38
AN:
176
East Asian (EAS)
AF:
AC:
12
AN:
264
South Asian (SAS)
AF:
AC:
18
AN:
246
European-Finnish (FIN)
AF:
AC:
129
AN:
900
Middle Eastern (MID)
AF:
AC:
0
AN:
18
European-Non Finnish (NFE)
AF:
AC:
857
AN:
4334
Other (OTH)
AF:
AC:
38
AN:
210
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.284
Heterozygous variant carriers
0
134
268
401
535
669
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Jun 20, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.